Endocrine Society applauds CMS announcement on therapeutic CGM coverage expansion

29 Mar 2017


The Endocrine Society praised the decision by Centres for Medicare & Medicaid Services (CMS) to extend access to therapeutic continuous glucose monitors (CGMs) to older Americans on intensive insulin therapy for diabetes.

Newswise


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story